Coronavirus COVID-19

Informatie voor UZA-patiënten en bezoekers | Reserveer hier een afspraak voor een PCR-test
Meer details Meer details



Research plays a central role within our group with expertise in national and international academic and industry sponsored clinical studies in the fields of hematology and oncology for more than 10 years. 

The collaboration with the Centre for Cell Therapy and Regenerative Medicine (CCRG) allows us to perform studies according to full GMP standards.

Research expertise

Hematological malignancies (e.g. ALL, AML, CLL, CML, HL, NHL, MM, MPD, MDS), hematopoietic stem cell transplantation, graft-versus host disease, dendritic cell immunotherapy, benign hematology (e.g. sickle cell anemia, thalassemia, ITP, immunodeficiencies) and thrombosis & hemostasis. 

Research infrastructure

All diagnostic and therapeutic tools for high-level hematological practice are available through collaboration with MOCA and CCRG.


Protocols and inclusion criteria can be found on:


A list of publications can be found on pubmed and within the annual UZA report.

Clinical trial leader

Prof. Dr. ZN Berneman, head Division of Hematology UZA and Medical Director CCRG

Research contact

  • Pascale De Graef, Clinical Trial Coordinator UZA
  • Jolien De Ryck, Clinical Trial Coordinator UZA
  • E: studies [dot] hematologie [at] uza [dot] be
  • T: +32 3 821 53 98